BECN) for $124.25 a share after its $11 billion takeover was rejected. Beacon adopted a poison pill after QXO announced its hostile bid for the building products company.

After enacting a “poison pill” defense to protect itself from unwanted potential buyers, Bausch Health has spotted a major ...

Beacon Roofing Supply is negotiating a potential $11 billion buyout from billionaire Brad Jacobs-run QXO, in a complete reversal after it rebuffed an earlier offer and adopted a poison pill to ...

Keros Therapeutics said on Thursday its board had authorized a stockholder rights plan, also known as a "poison pill", in response to rapid accumulations of the company's stock by some investors.

The level of tendered shares is above expectations at this stage, particularly since the Beacon Board has implemented a shareholder-unfriendly poison pill designed to obstruct the completion of ...